3 - Webinars Archives

Webinars

Use of Real-World Data for in-silico Trials and Innovative Designs: Recent Successes and Current Perspectives

October 2nd, 2025 1 minute read

Real-world data (RWD) are transforming clinical research. By supplementing randomized controlled trials (RCTs), RWD c...

Webinars

DMC Best Practices: What Biotechs and Sponsors Should Know

August 5th, 2025 1 minute read

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safet...

Webinars

Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials

May 27th, 2025 1 minute read

Sponsors working in rare diseases/running small population studies often have difficulties in demonstrating efficacy ...

Webinars

Leveraging Real-World Evidence: Data Sources, Challenges and Applications in Modern Clinical Trials

April 29th, 2025 1 minute read

Real World Evidence (RWE) plays a critical role across multiple pharma processes, including drug development, regulat...

Webinars

Novel Research in Early Phase Trials: Enhancing Efficiency of Combination Strategies

February 28th, 2025 1 minute read

Early phase trials play a crucial role in drug development, determining the dose to test in later phases. With the ri...

Webinars

Strengthening Causal Inference with Sensitivity Analyses: Using the Bayesian Parametric G-Formula

February 19th, 2025 2 minute read

Understanding causal relationships in real-world data is challenging, particularly in observational studies, where co...

Webinars

Mastering Clinical Trial Outsourcing: FSP Solutions from Industry Experts

November 25th, 2024 2 minute read

In Partnership With PCMG Phastar and PCMG partnered to start 2025 with an insightful fireside chat, sharing their ind...

Webinars

Navigating the Real- World: How to Better Utilize Real-World Evidence

October 29th, 2024 2 minute read

Real World Evidence (RWE) is playing an important role in the drug development process by providing valuable insights...

Webinars

EU HTA: Challenges and Opportunities

September 19th, 2024 1 minute read

With the upcoming introduction of the new EU HTA guidance in January 2025, sponsors in the pharmaceutical, Biotech an...

Webinars

Navigating Project Optimus: Implications for Oncology Drug Development

June 27th, 2024 2 minute read

With the launch of Project Optimus, the FDA is reforming the dose optimization and dose selection paradigm in oncolog...

Webinars

Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

March 7th, 2024 1 minute read

Complete the form below to watch the webinar Featuring: Moderated by Natalie Fforde, Senior Vice President, Global St...

Webinars

Implementing Additional Medidata Solutions

February 27th, 2024 1 minute read

Slides created by: Carly Baker, Director, Clinical Data Operations, and Kat Fogden, Principal Data Operations Program...

Webinars

The New Drug/Biologics License Applications Review Process. What’s all the Fuss?

January 29th, 2024 1 minute read

Presented by: LaRee Tracy, PhD, and Joshua Baker, PhD Complete the form below to watch the webinar

Webinars

Statistical Insights for Biotech Professionals

December 12th, 2023 1 minute read

Complete the form below to watch the webinar

Webinars

Understanding the Pitfalls of P-values and Hypothesis Tests

December 7th, 2023 1 minute read

Complete the form below to watch the webinar

Webinars

Study Design Considerations for Biotechs

November 30th, 2023 1 minute read

Complete the form below to watch the webinar

Webinars

Use of Expert Prior Elicitation for Clinical Research

November 16th, 2023 2 minute read

About this webinar The application of expert prior elicitation in clinical research serves as an important methodolog...

Webinars

A Four-step Strategy for Handling Missing Outcome Data in Randomised Trials Affected by a Pandemic

December 17th, 2021 1 minute read

Presented by: Professor James Carpenter | MRC Clinical Trials Unit, LSHTM Complete the form below to watch the webinar

Webinars

Introduction to Handling Efficacy Data in CDISC Standard Datasets

March 17th, 2021 1 minute read

Presented by: Kate Booth | Phastar Complete the form below to watch the webinar

Webinars

So, you want to meet the FDA? Preparing for Regulatory Meetings & How Statisticians can Influence these Interactions

November 19th, 2020 1 minute read

Presented by: LaRee Tracy, PhD, and Joshua Baker, PhD Complete the form below to watch the webinar

Webinars

The Role of Industry and FDA Statisticians

November 2nd, 2020 1 minute read

Presented by: LaRee Tracy, PhD, and Joshua Baker, PhD Complete the form below to watch the webinar

Webinars

Clearing the Fog: An introduction to LOINC codes

September 18th, 2020 1 minute read

Presented by: Jordan Bristow | Phastar Complete the form below to watch the webinar

Webinars

Blinded by the X-Rays? An Introduction to the Design of Radiotherapy Trials

September 16th, 2020 1 minute read

Presented by: Lucy McParland | Phastar Complete the form below to watch the webinar

Webinars

Data Management’s Role in Multi Stream Data Capture

August 30th, 2020 1 minute read

Presented by: Kirsty Millar | Phastar Complete the form below to watch the webinar

Webinars

ADaM Datasets – Why do we Produce Them?

August 28th, 2020 1 minute read

Presented by: Kate Booth | Phastar Complete the form below to watch the webinar

Webinars

Use of Real-World Data for in-silico Trials and Innovative Designs: Recent Successes and Current Perspectives

DMC Best Practices: What Biotechs and Sponsors Should Know

Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials

Leveraging Real-World Evidence: Data Sources, Challenges and Applications in Modern Clinical Trials

Novel Research in Early Phase Trials: Enhancing Efficiency of Combination Strategies

Strengthening Causal Inference with Sensitivity Analyses: Using the Bayesian Parametric G-Formula

Mastering Clinical Trial Outsourcing: FSP Solutions from Industry Experts

Navigating the Real- World: How to Better Utilize Real-World Evidence

EU HTA: Challenges and Opportunities

Navigating Project Optimus: Implications for Oncology Drug Development

Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

Implementing Additional Medidata Solutions

The New Drug/Biologics License Applications Review Process. What’s all the Fuss?

Statistical Insights for Biotech Professionals

Understanding the Pitfalls of P-values and Hypothesis Tests

Study Design Considerations for Biotechs

Use of Expert Prior Elicitation for Clinical Research

A Four-step Strategy for Handling Missing Outcome Data in Randomised Trials Affected by a Pandemic

Introduction to Handling Efficacy Data in CDISC Standard Datasets

So, you want to meet the FDA? Preparing for Regulatory Meetings & How Statisticians can Influence these Interactions

The Role of Industry and FDA Statisticians

Clearing the Fog: An introduction to LOINC codes

Blinded by the X-Rays? An Introduction to the Design of Radiotherapy Trials

Data Management’s Role in Multi Stream Data Capture

ADaM Datasets – Why do we Produce Them?

Speak to our Team of Experts